Cargando…
Efficacy of chimeric antigen receptor T cell therapy and autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma: A systematic review
BACKGROUND: We aimed to compare the efficacy of chimeric antigen receptor T (CAR-T) cell therapy with that of autologous stem cell transplantation (auto-HSCT) in relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL). RESEARCH DESIGN AND METHODS: We searched eligible publications up to Januar...
Autores principales: | Tian, Linyan, Li, Cheng, Sun, Juan, Zhai, Yixin, Wang, Jinhuan, Liu, Su, Jiang, Yanan, Wu, Wenqi, Xing, Donghui, Lv, Yangyang, Guo, Jing, Xu, Hong, Sun, Huimeng, Li, Yuhang, Li, Lanfang, Zhao, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886865/ https://www.ncbi.nlm.nih.gov/pubmed/36733398 http://dx.doi.org/10.3389/fimmu.2022.1041177 |
Ejemplares similares
-
A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma
por: Xu, Hong, et al.
Publicado: (2022) -
Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023) -
Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023) -
Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022) -
Prognostic Significance of Ribosome-related Genes Signature in Diffuse Large B Cell Lymphoma
por: Wu, Wenqi, et al.
Publicado: (2023)